31/05/2022 - Institutional news
The hospital is the only healthcare centre in Spain to form part of the group behind the project, which aims to create a mobile app platform to personalise patient monitoring for sufferers of this disease. The initiative will receive funding from the EU's HORIZON programme. Hospital del Mar's Pneumology Department is part of the TOLIFE project (Artificial Intelligence and Smart sensing TOward better management and improved quality of LIFE in chronic obstructive pulmonary disease). This is an international initiative to develop a tool that, using artificial intelligence, will improve and personalise the treatment of patients with chronic obstructive pulmonary disease (COPD).
04/02/2022 - Institutional news
This morning, Minister Diana Morant visited the facilities of the Hospital del Mar Medical Research Institute, accompanied by the manager of the Parc de Salut Mar, Dr. Olga Pané, the director of the IMIM, Dr. Joaquín Arribas, and the director of the IMIM's Cancer Research Programme, Dr. Juan Albanell. During the event, she visited the laboratory of the New Molecular Targets in Cancer Research Group and met with the heads of the IMIM's cancer research groups.
03/02/2022 - Institutional news
On 4 February, the XXIV Olympic Winter Games will be inaugurated in Beijing, which this year will be held under very strict COVID-19 control protocols. Three scientists from the IMIM Anti-Doping Laboratory, Rosa Ventura, Sergi Coll and Lídia Requena, will be travelling to Beijing to work in the Olympic laboratory. Rosa Ventura will be involved in the management and supervision group, Sergi Coll will be working on the detection of anabolic steroids, and Lídia Requena will be concentrating on the detection of hormones (erythropoietin, growth hormone). The Beijing Laboratory will analyse 3000 samples over the Olympic Games and another 600 during the Paralympic Games. This high volume of samples requires a great deal of analytical equipment and a large number of specialised professionals organised into shifts working around the clock.
20/01/2022 - Institutional news
The head of the Gastrointestinal Surgery Section of the Surgery Service of the Hospital del Mar and coordinator of the Gastroesophageal Carcinogenesis Research Group of the Hospital del Mar Medical Research Institute (IMIM-Hospital del Mar), thus becomes the only surgeon in the State to be an honorary member of this institution, in recognition of his career. Dr. Manuel Pera has become an honorary member of the European Board of Upper Gastrointestinal Surgery, within the European Union of Medical Specialists (UEMS) at the proposal of the institution's examining committee. So far, among the more than forty professionals who have obtained the Board, only three other surgeons from the State have managed to become fellows of the entity. Dr. Pera is the first to do so as an honorary member.
22/12/2021 - Institutional news
From 2022, the World Anti-Doping Agency's (WADA) list of prohibited substances and methods in sport is to include important changes regarding the use of glucocorticoids in sport. From this point on, all injectable methods will be prohibited during competitions, in addition to oral and rectal administration. Other ways of receiving the medication, such as via inhalation, intranasal or dermatological routes, will continue to be permitted if their use is necessary for therapeutic reasons. There will still be no restrictions on the use of glucocorticoids in out-of-competition periods. Criteria have also been defined to improve the safety of glucocorticoid administration for therapeutic reasons. Firstly, the distinction between prohibited and permitted routes of administration has been improved by defining a specific information concentration for each glucocorticoid. Secondly, blanking periods after prohibited treatments have been defined so that those performed in out-of-competition periods close to competitions do not lead to false positive results in samples collected during competitions.
22/12/2021 - Institutional news
The Director of the Addictions Process at INAD and researcher at the Hospital del Mar Medical Research Institute becomes a member of the executive committee of this organization that promotes knowledge and research on dual pathology. The congress of the World Association on Dual Disorders (WADD) approved at its congress, held in Paris between December 7 and 9, the incorporation of Dr. Marta Torrens to its executive committee. Thus, the Director of the Addictions Process of the Institute of Neuropsychiatry and Addictions of the Hospital del Mar (INAD) and coordinator of the Addictions Research Group of the Hospital del Mar Medical Research Institute (IMIM), will participate in the organization's decision-making, such as the organization of congresses, training courses and publications.
03/12/2021 - Institutional news
The Hospital del Mar Medical Research Institute (IMIM) has signed a five-year contract with the World Anti-Doping Agency (WADA, https://www.wada-ama.org/ ), within the framework of a tender of offers at an international level, worth € 1,880,000, for the preparation of reference materials for its external quality assessment program of laboratories (EQAS) accredited to carry out anti-doping control around the world (WADA's External Quality Assessment Scheme). Dr. Oscar Pozo, group leader of the Applied Metabolomics Research Group of the Neurosciences Research Program at IMIM, will be responsible for the execution of the contract as of January 2022.
29/11/2021 - Institutional news
The Emeritus Head of the Surgery Department at Hospital del Mar and researcher at the Hospital del Mar Institute of Medical Research became a full member of the RAMC, in a ceremony held on 29 November at the institution's headquarters. Dr. Lluís Grande is now a full member of the Royal Academy of Medicine of Catalonia. The appointment was made on 29 November, in a ceremony held at the institution's headquarters, in which the Emeritus Head of the Surgery Department at Hospital del Mar and researcher at the Hospital del Mar Institute of Medical Research (IMIM), delivered the speech, "Showing the data: a recipe for improving quality in an academic surgery department." The response was given by Dr. Laureà Fernández-Cruz, also a full member of the RAMC.
25/11/2021 - Institutional news
The emeritus head of both the Pneumology Service at Hospital del Mar and the Myogenesis, Inflammation and Muscle Function research group at the Hospital del Mar Medical Research Institute is one of the fourteen experts invited to participate. Dr. Joaquim Gea, emeritus head of both the Pneumology service at Hospital del Mar and the Myogenesis, Inflammation and Muscle Function research group at the Hospital del Mar Medical Research Institute (IMM), was one of the two international experts, and the only European, invited to participate in the drafting of the consensus document for the Colombian Association of Pneumology and Thoracic Surgery, on the follow-up and treatment of patients who have overcome COVID-19.
17/11/2021 - Institutional news
Stanford University has recently published an update of the list of the top 2% most widely cited scientists in different disciplines, the World's Top 2% Scientists. This ranking, considered the most prestigious worldwide, is based on the bibliometric information contained in the Scopus database and includes more than 180,000 researchers from the more than 8 million scientists considered to be active worldwide, with 22 scientific fields and 176 subfields taken into account. Of the dozen researchers from the IMIM and Hospital del Mar who appear on the list, special mention should be made of Dr. Jordi Mestres, coordinator of the GRIB (IMIM/UPF) systems pharmacology research group, who is ranked number 1 in Catalonia, number 5 in Spain and 263rd in the world in the Medicinal and Biomolecular Chemistry subfield out of the 88,725 researchers in this area. The research carried out by Dr. Mestres is at the interface between chemistry and biology, where the current focus is on the development of biocheminformatics tools and databases, the topographic analysis of molecular surfaces and the design of protocols for virtual screening.
Servei de Comunicació:
Marta Calsina Freixas(ELIMINAR)
Tel:
(+34) 93 316 06 80
Doctor Aiguader, 88
08226 Barcelona
© Institut Hospital del Mar
d'Investigacions MèdiquesLegal Notice and Privacy Policy | Cookie Policy | Site Index | Accessibility | Find Us | Contact
